Broader Medicaid Eligibility May Be a Tool for Reducing Substance Use Disorder-Related Deaths
Expanded Medicaid eligibility thresholds were associated with a reduction in substance use disorder-related deaths during the current US opioid epidemic.
Substance Use
Hearing Loss Before Age 50 Tied to Higher Substance Use
Hearing loss is independently associated with substance use disorders among those aged 49 years and younger.
Effect of Depression, Lifestyle on Cognitive Function in PLWHIV
Compared with patients without HIV, the poorer cognitive performances of PLWHIV were partly mediated by a higher prevalence of depressive symptoms.
Barriers in Substance Use Disorder Screening and Intervention for Youth Include Physician Training, Reimbursement
Physicians reported that a lack of training in brief intervention and reimbursement make providing screening and intervention more difficult when caring for youth with possible substance use disorders.
HHS Task Force Issues Draft Report on Best Practices for Pain Management
In a draft report issued December 28, 2018 by the US Department of Health and Human Services-sponsored Pain Management Best Practices Inter-Agency Task Force, recommendations for a multidisciplinary approach to pain management were formulated.
Medication Treatment for Substance Abuse Increased in Facilities
From 2007 to 2016, there was an increase in the proportion of substance use treatment facilities offering medication treatment.
Youths Who Use Marijuana Are at Increased Risk for Acute Psychotic Symptoms
Investigators examined whether adolescents who use marijuana heavily develop acute psychotic symptoms at a much higher rate than youths who use marijuana minimally or not at all.
Nonmedical Prescription Opioid Use Motivated by Pain Relief in Adolescence Predicts Later SUD
A set of characteristics of nonmedical use of prescription opioids in adolescents may help identify youth at high risk for substance use disorder, including opioid misuse, in early midlife.
Physical, Sexual Abuse and Concurrent Opioid/Benzodiazepine Use in Chronic Pain
Patients with chronic pain and a history of physical and sexual abuse were found to be more likely to concurrently use benzodiazepine and opioids.
Novel FAAH Inhibitor May Reduce Cannabis Withdrawal Symptoms in Men
The investigational fatty acid amide hydrolase inhibitor PF-04457845 may decrease cannabis withdrawal symptoms and dependence in men.
Next post in Addiction
